Evidence map›Paper›PMID 31892180›Full record

ReviewMolecules (Basel, Switzerland)2019

The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine.

Samer Bayda, Muhammad Adeel, Tiziano Tuccinardi, Marco Cordani, Flavio Rizzolio

Abstract readHistorical ArticleReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 440 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
440citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

440 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Green Synthesis and Characterization of SiOApplied biochemistry and biotechnology · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

380 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samer BaydaDepartment of Chemistry, Faculty of Sciences, Jinan University, Tripoli 818, Lebanon.ORCID 0000-0002-0101-731X
Muhammad AdeelPathology Unit, IRCCS CRO Aviano-National Cancer Institute, 33081 Aviano, Italy.
Tiziano TuccinardiDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-6205-4069
Marco CordaniInstituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), 28049 Madrid, Spain.ORCID 0000-0001-9342-4862
Flavio RizzolioPathology Unit, IRCCS CRO Aviano-National Cancer Institute, 33081 Aviano, Italy.ORCID 0000-0002-3400-4363

Funding

My First AIRC No. 15639
6 · The paper itself

Abstract

Nanoscience breakthroughs in almost every field of science and nanotechnologies make life easier in this era. Nanoscience and nanotechnology represent an expanding research area, which involves structures, devices, and systems with novel properties and functions due to the arrangement of their atoms on the 1-100 nm scale. The field was subject to a growing public awareness and controversy in the early 2000s, and in turn, the beginnings of commercial applications of nanotechnology. Nanotechnologies contribute to almost every field of science, including physics, materials science, chemistry, biology, computer science, and engineering. Notably, in recent years nanotechnologies have been applied to human health with promising results, especially in the field of cancer treatment. To understand the nature of nanotechnology, it is helpful to review the timeline of discoveries that brought us to the current understanding of this science. This review illustrates the progress and main principles of nanoscience and nanotechnology and represents the pre-modern as well as modern timeline era of discoveries and milestones in these fields.

Indexed as

History, 20th CenturyHistory, 21st CenturyHumansNanomedicineNanotechnologynanomaterialsnanomedicinenanoparticlesnanosciencenanotechnology

Identifiers

PMID31892180
PMCPMC6982820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.